Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 4, Issue 8, Page 5 (August 2009)


View previous. 8 of 44 View next.

Saxagliptin Approved by FDA for Type 2 Diabetes

MITCHEL L. ZOLER

The Food and Drug Administration approved saxagliptin (Onglyza), an oral, once-daily drug for treating type 2 diabetes in adults.

PII: S1558-0164(09)70226-3


View previous. 8 of 44 View next.